Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Pharmaceutical Research
|
June 22, 2011
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients
Michel Tod, Olivier Mir, Natacha Bancelin, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study
Maud Velev, Alicja Puszkiel, Benoit Blanchet, et al.
Plos One
|
August 23, 2012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study
Pascaline Boudou-Rouquette, Céline Narjoz, Jean Louis Golmard, et al.
Blood
|
September 28, 2002
Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors
Stéphane Giraudier, Hédia Chagraoui, Emiko Komura, et al.
Aging Cell
|
December 13, 2022
High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP
Léa Montégut, Adrien Joseph, Hui Chen, et al.
Clinical Biochemistry
|
January 7, 2015
Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells
Florian Lemaitre, Benoit Blanchet, Marianne Latournerie, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 2017
Potential drug-drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France
Clément Bonnet, Pascaline Boudou-Rouquette, Esther Azoulay-Rutman, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Pharmaceutics
|
July 27, 2022
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer
Perrine Courlet, Evelina Cardoso, Carole Bandiera, et al.
British Journal of Cancer
|
March 27, 2024
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Pharmaceutical Research
|
June 22, 2011
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients
Michel Tod, Olivier Mir, Natacha Bancelin, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study
Maud Velev, Alicja Puszkiel, Benoit Blanchet, et al.
Plos One
|
August 23, 2012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study
Pascaline Boudou-Rouquette, Céline Narjoz, Jean Louis Golmard, et al.
Blood
|
September 28, 2002
Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors
Stéphane Giraudier, Hédia Chagraoui, Emiko Komura, et al.
Aging Cell
|
December 13, 2022
High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP
Léa Montégut, Adrien Joseph, Hui Chen, et al.
Clinical Biochemistry
|
January 7, 2015
Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells
Florian Lemaitre, Benoit Blanchet, Marianne Latournerie, et al.
Cancer Chemotherapy and Pharmacology
|
April 1, 2017
Potential drug-drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France
Clément Bonnet, Pascaline Boudou-Rouquette, Esther Azoulay-Rutman, et al.
Pharmaceutics
|
September 23, 2022
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, et al.
Pharmaceutics
|
July 27, 2022
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer
Perrine Courlet, Evelina Cardoso, Carole Bandiera, et al.
British Journal of Cancer
|
March 27, 2024
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, et al.
Page
of 11